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Ventricular chamber morphogenesis, first man-
ifested by trabeculae formation, is crucial for
cardiac function and embryonic viability and
depends on cellular interactions between the
endocardium and myocardium. We show that
ventricular Notch1 activity is highest at pre-
sumptive trabecular endocardium. RBPJk and
Notch1 mutants show impaired trabeculation
and marker expression, attenuated EphrinB2,
NRG1, and BMP10 expression and signaling,
and decreased myocardial proliferation. Func-
tional and molecular analyses show that Notch
inhibition prevents EphrinB2 expression, and
that EphrinB2 is a direct Notch target acting up-
stream of NRG1 in the ventricles. However,
BMP10 levels are found to be independent of
both EphrinB2 and NRG1 during trabeculation.
Accordingly, exogenous BMP10 rescues the
myocardial proliferative defect of in vitro-cul-
tured RBPJk mutants, while exogenous NRG1
rescues differentiation in parallel. We suggest
that during trabeculation Notch independently
regulates cardiomyocyte proliferation and dif-
ferentiation, two exquisitely balanced pro-
cesses whose perturbation may result in con-
genital heart disease.
INTRODUCTION
Ventricular chamber formation is essential to heart devel-
opment and adult cardiac function (Moorman and Chris-
toffels, 2003). Maintaining the balance between cardio-Developmyocyte proliferation and differentiation is critical in this
process, as heart muscle cells must multiply rapidly to
sustain hemodynamic pressure and progress in their mat-
uration (Moorman and Christoffels, 2003). The trabeculae,
which are highly organized sheets of cardiomyocytes
forming muscular ridges lined by endocardial cells (Ben-
Shachar et al., 1985), form as a result of interactions be-
tween primitive myocardium and endocardium at the
end of cardiac looping (E9.0–E9.5 in mouse). These struc-
tures are a constant feature of the early vertebrate ventric-
ular chambers, and they represent the first andmost char-
acteristic sign of ventricular differentiation (Sedmera et al.,
1997). Trabeculae gradually becomepart of papillarymus-
cles, the interventricular septum, and cardiac conduction
system cells. Failure to differentiate may result in congen-
ital heart disease (CHD).
Not much is known about the genetic circuitry and mo-
lecular regulation of ventricular trabeculation. Only a few
pathways such as NRG1/ErbB2, 4 (Gassmann et al.,
1995; Lee et al., 1995; Meyer and Birchmeier, 1995), Eph-
rinB2/EphB4 (Wang et al., 1998; Gerety et al., 1999), and
BMP10 (Chen et al., 2004) have been shown to be involved
in this process. However, it is not clear how these different
molecular mechanisms are related, and intense research
is required to understand the complexity underlying ven-
tricular morphogenesis (Moorman and Christoffels, 2003).
Notch is a local signaling pathway that regulates embry-
onic cell fate determination, differentiation, and patterning
(reviewed in Artavanis-Tsakonas et al., 1999). Notch con-
stitutes an evolutionarily conserved group of type I trans-
membrane receptors (Notch1–Notch4 in mammals) that
have a large extracellular region and an intracellular do-
main (NICD), including two nuclear localization signals
and a transactivation region. The extracellular region of
Notch can interact with membrane-bound ligands of the
Delta or Serrate/Jagged families. A ligand binding-
induced signal is delivered to the nucleus in a processmental Cell 12, 415–429, March 2007 ª2007 Elsevier Inc. 415
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tase activity and nuclear translocation of NICD (Kopan,
2002). In the nucleus, NICD heterodimerizes with the
RBPJK/CBF1/Su(H) effector transcription factor (Fortini
and Artavanis-Tsakonas, 1994), converting it from a re-
pressor to an activator. Notch target genes include those
encoding basic-helix-loop-helix (bHLH) transcription fac-
tors of the Hes and HRT/Hey/Herp families (Iso et al.,
2003).
Specific Notch ligands, receptors, and targets are ex-
pressed in the heart from early developmental stages.
Delta4 (Krebs et al., 2000), Notch1 (Del Amo et al.,
1992), and Notch4 (Uyttendaele et al., 1996) are tran-
scribed in the endocardium from gastrulation onward,
whereas Jag1 and Notch2 show restricted expression in
the myocardium from midgestation (Loomes et al., 1999;
McCright et al., 2002). HRT1 and HRT2 show chamber-
specific expression in the endocardium and myocardium
(Nakagawa et al., 1999). Notch is required for endocardial
differentiation and formation of the cardiac valve primor-
dia (Timmerman et al., 2004). In Xenopus myocardium,
Notch appears to inhibit cardiomyogenesis (Rones et al.,
2000; Schroeder et al., 2003), and manipulation of Notch
signaling in vitro is consistent with this finding (Schroeder
et al., 2003; Nemir et al., 2006). Further in vivo studies in-
dicate that Notch signaling inhibits myocardial differentia-
tion (Watanabe et al., 2006) and participates in cardiac
patterning (Rutenberg et al., 2006), although its mecha-
nism of action is not well understood. HRT2 appears to
be an important Notch mediator in the heart (reviewed in
Kokubo et al., 2005), but additional targets remain to be
identified.
In this study, we have addressed the role of Notch in
ventricular chamber development. We find that Notch1
activity is highest at presumptive trabecular endocardium
and, as development proceeds, concentrates at the base
of trabeculae. RBPJk and Notch1mutants show impaired
trabeculation and marker expression, attenuated Eph-
rinB2, NRG1, and BMP10 expression and signaling, and
decreased myocardial proliferation. Functional and mo-
lecular analyses show that Notch inhibition prevents Eph-
rinB2 expression, and that EphrinB2 is a direct Notch tar-
get acting upstream of NRG1 in the ventricles. However,
BMP10 levels are found to be independent of both Eph-
rinB2 and NRG1 during trabeculation. Accordingly, exog-
enous BMP10 rescues the myocardial proliferative defect
of in vitro-cultured RBPJk mutants, while exogenous
NRG1 rescues their differentiation defect. We suggest
that Notch coordinates an interaction between ventricular
endocardium and myocardium that is critical for trabecu-
lation, through two distinct Notch-dependent processes:
(1) the transition of primitive myocardial epithelium to tra-
becular and compact myocardium, mediated by the Eph-
rinB2-dependent endocardial paracrine factor NRG1, and
(2) the maintenance of a BMP10-dependent proliferating
cardiomyocyte population in the trabeculae. We discuss
the role of Notch signaling in regulating cardiomyocyte
proliferation/differentiation equilibrium, and we suggest
that altered Notch signaling may directly relate to CHD416 Developmental Cell 12, 415–429, March 2007 ª2007 Elsevinvolving defective cardiomyogenesis, as seen in human
cardiac valve development (Garg et al., 2005).
RESULTS
Endocardial Notch Signaling in Trabecular
Development
Delta4 and Notch1mRNA are expressed in E8.5 endocar-
dium (Timmerman et al., 2004). At E9.5, Delta4 and Delta1
levels were particularly high in endocardium at the base of
ventricular trabeculae (Figures 1A, 1B, 1D, and 1E). In con-
trast, Notch1 transcription appeared to be uniform
throughout ventricular endocardium (Figures 1C and 1F).
To ascertain whetherDelta4 andDelta1 ventricular tran-
scription indicates the site of Notch activation, we stained
E8.5–E9.5 embryos with an antibody to the activated form
of Notch1 (N1ICD). At E8.5, N1ICD was strongly ex-
pressed in the endocardium of the prospective trabecular
region (Figures 1G and 1H) and overlapped with Delta4 at
this stage (Figure 1I). At E9.0, endocardial N1ICD expres-
sion was stronger at the base of developing trabeculae
and was reduced at the distal end (Figures 1J–1L). At
E9.5, N1ICD was predominantly expressed in the endo-
cardium at the base of trabeculae (Figures 1M and 1N)
and was expressed to a lesser extent in interventricular
endocardium (Figure 1M). High-resolution fluorescence
and confocal image analysis showed that N1ICD endocar-
dial staining reduced progressively from the base to the
distal end of trabeculae (Figures 1N and 1O; Figure S1
and Movie S1, see the Supplemental Data available with
this article online). These results indicated active endocar-
dial Notch signaling prior to and during ventricular trabe-
culation, leading us to study whether this process was
impaired in Notch pathway mutants.
Notch Pathway Mutants Show Defective
Trabeculation and Marker Expression
We have studied standard targeted Delta1 (Hrabe de An-
gelis et al., 1997),Notch1 (Conlon et al., 1995), and RBPJk
mutants (Oka et al., 1995). In addition, we have compared
our data with results obtained with conditional Notch1
(Radtke et al., 1999) and RBPJk (Han et al., 2002) alleles
deleted in the endocardium by breeding them with Tie2-
CRE/+ transgenic mice (Kisanuki et al., 2001). We ana-
lyzed serial sections of E8.5–E10.5 Notch1 and RBPJk
mutants for ventricular abnormalities (Figures 2B–2P;
planes of section in Figure 2A). In E9.5 wild-type (WT) em-
bryos, both the left and right ventricles showed developing
trabeculae growing toward the ventricular lumen (Figures
2B and 2E). In contrast, RBPJk (Figures 2C and 2F) and, to
a lesser extent, Notch1 mutants (Figures 2D and 2G) had
poorly developed trabeculae and a less-structured myo-
cardium. We found no obvious cardiac defects in Delta1
mutants at E9.5 (data not shown), suggesting functional
redundancy among these ligands.
Scanning electron microscopy (SEM) revealed well-
organized trabeculae in WT embryos, with close apposi-
tion of the endocardium and myocardium (Figure 2H).
However, in RBPJk (Figure 2I) and Notch1 (Figure 2J)ier Inc.
Figure 1. Notch Is Active in the Developing Trabeculae
(A–F) Delta4, Delta1, and Notch1 transcription in E9.5 WT heart by WISH. (A and D) Delta4 and (B and E) Delta1 transcribe preferentially in the endo-
cardium at the base of trabeculae (arrows); little or no transcript is detected in distal endocardium (arrowheads). (C and F) Notch1 is uniformly tran-
scribed in ventricular endocardium (arrow and arrowhead).
(G–N) N1ICD staining (red); nuclei are counterstained with DAPI (blue). (G and H) (G) General heart view at E8.5 and (H) detail of the ventricle. Note the
strong N1ICD expression in the endocardium at the base of presumptive trabeculae (arrows) and no signal in distal endocardium (arrowhead). (I)
Delta4 transcription at the base of nascent trabeculae (arrows) at E8.5. (J) E9.0 general heart view; note the strong N1ICD staining in both ventricles.
(K and L) (K) Left and (L) right ventricles with strong N1ICD staining in the endocardium at the base of trabeculae (arrows), and no signal in distal en-
docardium (arrowhead). (M) E9.5 general heart view; note the strong N1ICD expression in ventricles and atrium, and the weaker expression in inter-
ventricular endocardium (arrow). (N) Detail of trabecula in the left ventricle. Note the strong N1ICD expression at the base (arrows) and a progressively
reduced signal at the middle (thin arrows) and distal tip (arrowheads).
(O) Schematic representation of the trabecula shown in (N). The red color indicates strong N1ICD staining, and the pink color indicates weak staining.
at, atrium; end, endocardium; myoc, myocardium; ph, pharynx; lv, left ventricle; rv, right ventricle; v, ventricle. All panels are transverse sections. The
scale bar is 100 mm in (A)–(C), (G), (J), and (M); 25 mm in (D)–(F), (H), (I), (K), and (L); 80 mm in (G); and 15 mm in (N).
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dium, which showed irregular thickness. RBPJk mutants
had a more severe phenotype than Notch1 mutants,Develosuggesting functional redundancy of Notch receptors in
trabeculation. CD31/PECAM expression revealed a close
endocardium:myocardium apposition in the developingpmental Cell 12, 415–429, March 2007 ª2007 Elsevier Inc. 417
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Notch Is Essential for Ventricular DevelopmentFigure 2. Defective Trabeculation in E9.5 Notch1 and RBPJk Mutants
(A–P) (A) Schematic representation of E9.5 WT or Notch1 (left) and RBPJk (right) mutant hearts, depicting a lateral view of cardiac chambers. Section
levels shown in (B)–(P) are indicated. In RBPJk mutants, the ventricles are aligned along the A-P axis. avc, AV canal; oft, outflow tract. (B–G) H&E-
stained transverse sections and (H–J) SEM photomicrographs. (B–D) General views of representative (B) WT, (C) RBPJk, and (D) Notch1 mutants
at the level of ventricles. (E and H) Details of WT left ventricle; note the developing trabeculae with (E and H) myocardium (arrows) and endocardium
(arrowheads); left ventricles of (F and I) RBPJk and (G and J) Notch1 mutants. RBPJk and Notch1 embryos show collapsed endocardium (arrow-
heads), disorganized myocardium (arrows), and poorly developed trabeculae. (K–M) Endocardial CD31/PECAM staining (arrowheads) in the left ven-
tricle of (K) WT, (L) RBPJk, and (M) Notch1 embryos. In WT trabeculae, the myocardium (arrow) is surrounded by endocardium (arrowhead). Arrow-
heads in (L) and (M) show the endocardium, and arrows indicate themyocardium. (N–P)MLC2v staining in (N)WT, (O)RBPJk, and (P)Notch1 embryos
shows MLC2v expression throughout the myocardium, including the trabeculae (arrow). Arrowheads indicate the endocardium.
la, left atrium; oft, outflow tract; ra, right atrium. The scale bar is 100 mm in (B)–(D) and 25 mm in (E)–(P).trabeculae inWT embryos (Figure 2K), whereas there were
abnormally few contacts between these tissues in RBPJk
and Notch1 mutants (Figures 2L and 2M). To determine
whether ventricular myocardium cell fate determination
was affected in Notch mutants, we analyzed expression418 Developmental Cell 12, 415–429, March 2007 ª2007 Elsevof the contractility marker MLC2v. E9.5 WT embryos
showed MLC2v expression in developing compact zone
myocardium and trabeculae (Figure 2N). Likewise, RBPJk
(Figure 2O) and Notch1 mutants (Figure 2P) expressed
MLC2v throughout the myocardium, including the poorlyier Inc.
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tion markers such as a-cardiac actin, smooth muscle
a-actin, and Irx4 were expressed in RBPJk mutants
(Figure S2), indicating that early ventricular myocardial dif-
ferentiation was unaffected.
To study the consequences of Notch deletion on ven-
tricular patterning and trabeculation, we used whole-
mount in situ hybridization (WISH) and semiquantitative
RT-PCR to analyze expression of endocardium (Irx5) and
myocardium (HOP, Irx3, PEG1) trabecular markers.
Figure S3 shows that expression of these genes was se-
verely reduced in RBPJk mutants, indicating that disrup-
tion of Notch ligand/receptor interactions between endo-
cardial cells affects interactions with myocardial cells
and impairs trabecular differentiation. As communication
between the endocardium and myocardium is critical for
trabeculation (Meyer and Birchmeier, 1995), we studied
the signaling pathways involved in this process.
Defective BMP10 Signaling and Cardiomyocyte
Proliferation in Notch Pathway Mutants
The cytokine BMP10 is expressed in trabecular myocar-
dium at E9.5 (Figures 3A and 3C) (Chen et al., 2004).
BMP10 mutants show impaired ventricular trabeculation,
caused by defective cardiomyocyte proliferation (Chen
et al., 2004). BMP10 transcription was greatly reduced in
RBPJk mutants, as WISH (Figures 3B and 3D) and RT-
PCR analysis (Figure 3H) showed, indicating that Notch
is required for BMP10 expression. To assess the BMP10
signaling reduction in RBPJk mutants, we used an anti-
body specific for phosphorylated Smad1/5/8 proteins,
which transduce the BMP10 signal to the nucleus (Mazer-
bourg et al., 2005). Phospho-Smad1/5/8 expression in
ventricular myocardium (Figure 3E) was reduced in RBPJk
mutants (Figure 3F). In contrast, similar phospho-Smad1/
5/8 staining was observed in the outflow tract region of
E9.5 WT (Figure S4A) and RBPJk mutants (Figure S4B),
presumably because other TGFb family members such
as BMP2 (Mazerbourg et al., 2005) activate Smad1/5/8
in this region. To quantify chamber-specific differences
between WT and RBPJk mutants in phospho-Smad1/5/
8 expression, we carefully separated the ventricles from
the outflow tract and atrioventricular (AV) canal regions.
Ventricle-specific western blot revealed a marked (60%)
reduction in phospho-Smad1/5/8 expression in RBPJk
mutants (Figure 3G), indicating that BMP10-dependent
signaling was affected in this tissue.
To assess whetherBMP10 downregulation affected cell
proliferation in Notch mutants, we analyzed both the S
(measuring BrdU incorporation into DNA) and mitosis
phases of the cell cycle (by using an anti-phospho histone
H3 [PHH3] antibody). At E9.5, numerous BrdU+ cells were
found in WT myocardium (35% of total cells; n = 10 em-
bryos; Figures S4C and S4E), whereas RBPJk mutants
showed a drastic reduction in BrdU+ cells (<15%; n = 6;
Figures S4D and S4E). Approximately 6%–8% of nuclei
in WT myocardium were PHH3+ (n = 6; Figures S4F and
S4H), whereas only 2% of nuclei stained positive inRBPJk
mutants (n = 4; Figures S4G and S4H). The predominanceDevelopof BrdU+myocardial cells in the E10.5 compact zonemyo-
cardium (Figures S5A and S5B) correlated with endocar-
dial N1ICD+ cells at the base of trabeculae (Figures S5C
and S5D), suggesting that endocardial Notch signaling is
required for cardiomyocyte proliferation. As BMP10 an-
tagonizes the cell cycle kinase inhibitor p57Kip2 (Chen
et al., 2004), we tested whether its expression was in-
creased in RBPJk mutants. p57Kip2 was expressed pri-
marily in endocardium of WT embryos, and few p57Kip2+
cells were detected in the myocardium (n = 5; Figures
S4I and S4K) (Chen et al., 2004). RBPJk mutants showed
a 40% increase in p57Kip2 expression (n = 5; Figures S4J
and S4K), consistent with their reduced myocardial
BMP10 expression (Figures 3B and 3D). Our data indicate
that Notch is required to sustain cardiomyocyte prolifera-
tion, via BMP10, during trabeculation.
Defective NRG1 and EphrinB2 Signaling in Notch
Pathway Mutants
The signaling pathway represented by the ligand NRG1
and the ErbB receptors is essential for trabeculation
(Gassmann et al., 1995; Lee et al., 1995; Meyer and Birch-
meier, 1995). NRG1 acts as a paracrine signal in the myo-
cardium, leading to ErbB4-ErbB2 dimerization and stimu-
lation of ErbB2 intrinsic tyrosine kinase activity (Falls,
2003). WT E9.5 NRG1 expression in ventricular endocar-
dium (Figures 3I, 3K, and 3H) (Meyer and Birchmeier,
1995) was greatly reduced in RBPJk mutants (Figures
3H, 3J, and 3L). In contrast, ErbB2 and ErbB4 were nor-
mally expressed in the myocardium of Notch mutants
(Figure 3H and data not shown). ErbB2 also heterodimer-
izes with ErbB3 (Falls, 2003), which is exclusively ex-
pressed in AV canal endocardial cushion mesenchyme
(Meyer and Birchmeier, 1995) (Figures S6A, S6C, and
S6E). ErbB3 is required for endocardial cushion develop-
ment (Erickson et al., 1997), similarly toNotch (Timmerman
et al., 2004), and ErbB3 expression was reduced in the AV
canal ofRBPJkmutants (Figure 3H; Figures S6B, S6D, and
S6F). NRG1 pathway activation was assessed by western
blot. E9.5WTandRBPJkmutant ventricles showed similar
total ErbB2 levels (Figure 3M). In contrast, extracts probed
with anti-phospho-ErbB2 antibody showed a marked re-
duction (60%) in the amount of phosphorylated ErbB2 in
RBPJk mutants (Figure 3M). These results indicate that
Notch is required for endocardial NRG1 expression.
The EphrinB2/EphB4 membrane-bound ligand/recep-
tor system is required for cardiovascular development,
including trabeculation (Wang et al., 1998; Gerety et al.,
1999). Both EphrinB2 (Figures 3N and 3P) (Wang et al.,
1998) and EphB4 (Figures 3R and 3T) (Gerety et al.,
1999) are expressed in WT endocardium. EphrinB2 ex-
pression was drastically reduced in RBPJk mutants (Fig-
ures 3H, 3O, and 3Q), whereas EphB4 expression was
increased (Figures 3H, 3S, and 3U), indicating that Notch
is needed for endocardial EphrinB2 and EphB4 expres-
sion. During vascular development, EphrinB2 marks arte-
rial endothelium, and EphB4 marks vein endothelium
(Wang et al., 1998). The observation that Notch mutants
show loss of EphrinB2 and increased EphB4 expressionmental Cell 12, 415–429, March 2007 ª2007 Elsevier Inc. 419
Developmental Cell
Notch Is Essential for Ventricular DevelopmentFigure 3. Impaired BMP10, NRG1, and EphrinB2 Expression and Activity in RBPJk Mutants
(A–D) BMP10 transcription in (A and C) E9.5 WT trabecular myocardium is reduced in (B and D) RBPJk mutants.
(E and F) P-Smad1/5/8 ventricular expression in (E) WT myocardium (arrow) is reduced in (F) RBPJk mutants (arrow).
(G) Left: western blot with anti-P-Smad1/5/8 antibody in WT and RBPJk mutant ventricles. Right: ratio of P-Smad1/5/8 expression to actin.
(H) Semiquantitative RT-PCR analysis in E9.5 WT and RBPJk mutant hearts.
(I–L) (I and K) WT endocardial NRG1 expression is reduced in (J and L) RBPJk mutants.
(M) Western blot of E9.5 cardiac extracts shows no RBPJK protein expression, relatively normal ErbB2 receptor levels, and reduced activated ErbB2
receptor levels (P-ErbB2) in RBPJk mutants. Top right: ratio of total ErbB2 levels in WT and mutants. Bottom right: ratio of P-ErbB2 to total ErbB2
levels.
(N–Q) (N and P) EphrinB2 expression in WT endocardium is greatly reduced in (O and Q) RBPJk mutants.420 Developmental Cell 12, 415–429, March 2007 ª2007 Elsevier Inc.
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of the endothelium, would be ‘‘vein.’’
We examined EphrinB2 signaling activity by using ven-
tricular extracts precipitated with anti-pTyr and probed
with anti-phospho-EphrinB2 antibody. The results showed
severe reduction (80%) of phospho-EphrinB2 levels in
RBPJkmutants (Figure 3V), most likely as a consequence
of reduced EphrinB2 expression. These data indicate that
cardiac NRG1- and EphrinB2-dependent signaling is
greatly reduced in RBPJk mutants.
Endocardial-Specific Notch1 or RBPJk Deletion
Impairs BMP10, NRG1, and EphrinB2 Expression
To demonstrate that the molecular phenotypes observed
were caused specifically by the abrogation of Notch1 en-
docardial function, we deleted Notch1 or RBPJk in the en-
docardium, by using conditional Notch1 (Radtke et al.,
1999) and RBPJk (Han et al., 2002) lines, that we bred
with Tie2-CRE mice (Kisanuki et al., 2001). WISH analysis
of E9.5 embryos showed normal endocardial EphrinB2
expression in WT embryos (Figures 4A and 4A0); in con-
trast, N1lox/N1lox; Tie2-CRE/+ (n = 5; Figures 4B and 4B0)
and RBPJklox/RBPJklox; Tie2-CRE/+ (n = 4; Figures 4C
and 4C0) mutants showed severely reduced EphrinB2 ex-
pression. Comparison of NRG1 transcription in WT (Fig-
ures 4D and 4D0), N1lox/N1lox; Tie2-CRE/+ (n = 5; Figures
4E and 4E0), and RBPJklox/RBPJklox; Tie2-CRE/+ (n = 4;
Figures 4F and 4F0) embryos showed a strong reduction
in both mutants, which was more drastic in RBPJklox/
RBPJklox; Tie2-CRE/+ embryos (Figure 4F0). The reduction
of BMP10 transcription in trabecular myocardium (Figures
4G and 4G0) was milder in N1lox/N1lox; Tie2-CRE/+ em-
bryos (4 out of 6 embryos; Figures 4H and 4H0) than in
RBPJklox/RBPJklox; Tie2-CRE/+ mutants (n = 4; Figures
4I and 4I0), suggesting functional redundancy at the recep-
tor level. These results demonstrate that the molecular
phenotypes observed in standard RBPJk andNotch1mu-
tants are due to the abrogation of Notch1-dependent sig-
naling in the endocardium.
NRG1 Acts Downstream of EphrinB2 and
Independently of BMP10 during Trabeculation
Wehave shown that cardiacBMP10,NRG1, andEphrinB2
expression depends on Notch signaling. To determine
whether these molecules function in a common pathway
during trabeculation, we first analyzed by WISH the onset
of their expression during cardiogenesis. We detected
EphrinB2 (Figure S7A) andNRG1 (Figure S7B) endocardial
expression in early E8.0 (six somites) WT embryos. In con-
trast, BMP10 transcription was not detectable in the E8.0
heart (Figure S7C). At E9.0 (12 somites), endocardial Eph-
rinB2 (Figure S7D) andNRG1 (Figure S7E) expression was
maintained, and we could barely detect BMP10 in the
myocardium (Figure S7F). Then, we analyzed EphrinB2,DevelopNRG1, and BMP10 expression in the appropriate mutant
backgrounds. Endocardial EphrinB2 expression (Figures
4A and 4A0) was normal in NRG1 (n = 6; Figures 4J and
4J0) and BMP10 (n = 4; Figures 4K and 4K0) mutants. Like-
wise, endocardial NRG1 expression (Figures 4D and 4D0)
was unaffected in BMP10 mutants (n = 4; Figures 4L and
4L0). In contrast, NRG1 expression was severely reduced
in EphrinB2 mutants (n = 6; Figures 4M and 4M0), indicat-
ing that its transcription depends on EphrinB2, but not on
BMP10. NormalBMP10 transcription (Figures 4G and 4G0)
in NRG1 (n = 5; Figures 4N and 4N0) and EphrinB2 (n = 6;
Figures 4O and 4O0) mutants indicated that its expression
does not depend on NRG1 and EphrinB2. These results,
together with the early (E8.0) cardiac expression of Eph-
rinB2 and NRG1, but not BMP10, indicate that EphrinB2
acts upstream of NRG1 and that BMP10 is independent
of both pathways during trabeculation.
Normal Cellular Proliferation and Impaired
Myocardial Differentiation in EphrinB2 and NRG1
Mutants
As both EphrinB2 and NRG1 have been shown to depend
on Notch for their expression, an analysis of proliferation
and differentiation in EphrinB2 andNRG1mutants was re-
quired. Ventricular cell proliferation measured by BrdU in-
corporation was similar, and was relatively normal, in WT
embryos (n = 10; 35%; Figures 5A and 5O and Figures
S4C and S4E) and in EphrinB2 (n = 4; Figures 5B and 5O)
and NRG1mutants (n = 6; Figures 5C and 5O). Ventricular
differentiation was examined by WISH by using a PEG1
probe. PEG1 expression in trabecular myocardium and
endocardium (Figure 5D) (King et al., 2002) was markedly
reduced in EphrinB2 (n = 4; Figure 5E) and NRG1mutants
(n=6; Figure 5F), suggesting that bothEphrinB2andNRG1
are required for ventricular myocardial differentiation.
NRG1 Rescues Differentiation, while BMP10
Rescues Proliferation Defects of Cultured Notch
Pathway Mutants
To test whether the secreted NRG1 andBMP10 are the ef-
fectors of pathways involved in ventricular myocardium
proliferation and differentiation, we cultured whole E8.5
RBPJk mutant embryos from heterozygous intercrosses
in normal (control) media, NRG1-containing media,
BMP10-containing media, or media containing NRG1
plus BMP10. After 19 hr of culture and BrdU addition, we
processed the embryos for proliferation or WISH analysis.
Figures 5G and 5O show extensive BrdU incorporation in
the ventricle of culturedWT embryos (35%; n = 8), similar
to our in vivo observations (Figure 5A and Figures S4C and
S4E). As previously described (Figures S4D and S4E),
RBPJkmutants cultured in control media showed reduced
BrdU incorporation (<10%; n = 8; Figures 5H and 5O), sim-
ilar to embryos cultured inNRG1-containingmedia (<10%;(R–U) (R and T) Endocardial EphB4 expression is increased in (S and U) RBPJK mutants.
(V) Immunoprecipitation with pTyr and western blot with anti-phosphorylated EphrinB2 antibody. Right: normalized phospho-EphrinB2 levels.
In (G), (M), and (V), representative results from three experiments with two independent sets of extracts are shown. Arrows in (C)–(F) show the myo-
cardium, and arrowheads show the endocardium. All sections show the left ventricle. The scale bar is 25 mm.mental Cell 12, 415–429, March 2007 ª2007 Elsevier Inc. 421
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Mutants
(A–O0)WISH, E9.5. (A andA0)EphrinB2 expression inWTembryos; reduction in (B andB0)Notch1lox/lox; Tie2-CRE and (CandC0)RBPJk lox/lox; Tie2-CRE
mutants. (D and D0) NRG1 expression in WT; reduction in (E and E0) Notch1lox/lox; Tie2-CRE and (F and F0) RBPJklox/lox; Tie2-CREmutants. (G and G0 )
BMP10 expression inWT; reduction in (H andH0)Notch1lox/lox; Tie2-CRE and (I and I0)RBPJklox/lox; Tie2-CREmutants. NormalEphrinB2 transcription in
E9.5 (J and J0 )NRG1 and (K and K0)BMP10mutants. NormalNRG1 expression in (L and L0)BMP10mutants, andmarked reduction in (M andM0) Eph-
rinB2mutants.BMP10 expression in (N andN0)NRG1 and (O andO0)EphrinB2mutants. Arrowheads point to the endocardium, and arrows point to the
myocardium. Asterisks indicate endocardial cushion of the AV canal, devoid of mesenchymal cells in EphrinB2mutants. The scale bar is 25 mm.n = 9; Figures 5I and 5O). In contrast, RBPJkmutants cul-
tured in media with NRG1 plus BMP10 showed a clear in-
crease in proliferation (27%; n = 10; Figures 5J and 5O).
Similar results were obtainedwithRBPJkmutants cultured
with BMP10 alone (25%; n = 9; Figure 5O and data not422 Developmental Cell 12, 415–429, March 2007 ª2007 Elsevshown), suggesting that the effectwasBMP10dependent.
We then examined expression of the ventricular
differentiation marker PEG1 in cultured embryos. PEG1
trabecular myocardial and endocardial expression in cul-
tured WT embryos (Figure 5K; 8 out of 8 embryos) wasier Inc.
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Notch Is Essential for Ventricular DevelopmentFigure 5. Cardiac Proliferation andMarker Analysis of EphrinB2 andNRG1Mutants and In Vitro Cytokine Rescue Experiment with
RBPJk Mutants
(A–C) BrdU staining in endocardium and myocardium of E9.5 (A) WT, (B) EphrinB2, and (C) NRG1 mutants. Positive cells in the endocardium are in-
dicated with arrowheads, and positive cells are indicated with arrows in the myocardium.
(D–F) PEG1 expression in trabecular myocardium and endocardium of (D) WT embryo, and severe reduction in (E) EphrinB2 and (F) NRG1 mutants.
Arrowheads indicate the endocardium, and arrows indicate the myocardium.
(G–J) BrdU staining in (G) WT and RBPJk mutants cultured in (H) control media, (I) media with NRG1, and (J) media with NRG1 plus BMP10.
(K–N) PEG1 expression in (K) WT and RBPJk mutants cultured in (L) control media, (M) media with NRG1, and (N) media with NRG1 plus BMP10.
(O) Quantification of BrdU incorporation. The values are means of BrdU-positive nuclei. The number of embryos analyzed is indicated in parentheses
inside of the histograms. Error bars represent the standard deviation (SD) of the data from the genotype and culture condition indicated in the figure.
The scale bar is 40 mm.Developmental Cell 12, 415–429, March 2007 ª2007 Elsevier Inc. 423
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the Endocardium
(A–D) WISH showing EphrinB2 expression in
E9.5 (A and C) DMSO control (arrowhead)
and severe reduction in (B and D) DAPT-
treated embryos (arrowhead). The scale bar is
25 mm in (C) and (D).
(E) ChIP assays. Chromatin from E9.5 WT and
RBPJkmutant hearts, MEF, and HMEC-1 cells
was immunoprecipitated with monoclonal
(mAb) or polyclonal (PAb) antibodies against
RBPJK or N1ICD. The EphrinB2 genomic
DNA was analyzed for RBPJK-binding sites A
and B. ‘‘Input’’ corresponds to PCR products
generated by using DNA from nonimmunopre-
cipitated chromatin as a template. —, no anti-
body was added to the reaction mixture.
(F) Luciferase reporter assays. HMEC-1 cells
were cotransfected with Renilla luciferase
plasmid and 100 or 150 ng N1ICD, Su(H)DBM
effector plasmid, or a control plasmid (empty
pCS2 vector), in combination with a reporter
plasmid containing WT RBPJK-binding sites
(A or B) or mutated ones (A* or B*). Data repre-
sent the means of four independent experi-
ments performed in triplicate. Error bars repre-
sent the SD of the data.
(G) HMEC-1 cells transfected with empty vec-
tor, N1ICD, or Su(H)DBM and RBPJk reporter
plasmid. After normalization to Renilla lucifer-
ase activity, firefly luciferase activity relative
to that of control plasmid was calculated for
each reporter. Data represent the means of
four independent experiments performed in
triplicate. Error bars represent the SD of the
data.severely reduced inRBPJkmutants cultured in controlme-
dia (Figure 5L; 7 out of 7), as observed in vivo (Figures S3N,
S3P, and S3Q). In contrast, RBPJk mutants cultured in
NRG1-containing media (Figure 5M; 6 out of 8) or in media
containing both cytokines (Figure 5N; 7 out of 9) showed
normal PEG1 expression, suggesting that the effect
was NRG1 dependent. These results indicate that the
myocardial proliferation defect of Notchmutants is caused
by their reduced BMP10 expression, while the differentia-
tion defect is due to the low NRG1 levels.424 Developmental Cell 12, 415–429, March 2007 ª2007 ElsevEphrinB2 Is a N1ICD/RBPJK Target
To further substantiate the relationship of Notch with the
EphrinB2, NRG1, and BMP10 pathways, we cultured
E8.5 WT embryos in media containing DMSO or DAPT,
a g-secretase inhibitor (Dovey et al., 2001). After 16 hr of
culture, no obvious effect was observed on NRG1 or
BMP10 expression in DAPT-treated and DMSO control
embryos (Figure S8). In contrast, whereas DMSO-cultured
embryos showed normal EphrinB2 expression (n = 26;
Figures 6A and 6C), DAPT-treated embryos showedier Inc.
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6B and 6D), suggesting a direct dependence of EphrinB2
expression on Notch activity. The persistence of NRG1
and BMP10 expression in DAPT-cultured embryos may
be due to the relatively short period of culture, which
may have prevented us from detecting changes in expres-
sion that may indirectly depend on Notch.
To test whether Notch1/RBPJK controls EphrinB2 ex-
pression directly, we carried out in silico analysis of this lo-
cus (Figure S9). We identified two RBPJK core consensus
binding sites (50-GTGGGAA-30) (Bailey and Posakony,
1995) that are evolutionarily conserved among mouse,
rat, monkey, and humans. The first site (A) is locatedwithin
the first intron, close to exon 2, and the second site (B) is at
the beginning of intron 2 (Figure S9). We performed chro-
matin immunoprecipitation (ChIP) assays with one anti-
N1ICD antibody and two anti-RBPJK antibodies (see
Experimental Procedures), using nuclear extracts from
E9.5 WT and RBPJk hearts. We used the human micro-
vasculature endothelial cell line HMEC-1 as in vitro model
and mouse embryonic fibroblasts (MEF) as negative con-
trols, as they express no detectable EphrinB2 (not shown).
The different antibodies immunoprecipitated chromatin
from WT embryos and HMEC-1 cells extracts, but not
from RBPJk mutants or MEF control extracts (Figure 6E).
These results demonstrated specific binding of the
N1ICD/RBPJK complex to these two sites in the EphrinB2
genomic DNA.
To confirm that N1ICD/RBPJK binding to these sites ac-
tivates EphrinB2 expression, we performed luciferase re-
porter assays with HMEC-1 cells. Two different EphrinB2
genomic fragments spanning either site A or site B were
cloned upstream of the firefly luciferase gene. HMEC-1
cells transfected with empty vector (pCS2) showed basal
luciferase activity with both site A and site B reporter con-
structs (Figure 6F). In contrast, N1ICD was able to tran-
siently activate this EphrinB2 reporter constructs up to
4.5-fold in a dose-dependent fashion in HMEC-1 cells
(Figure 6F; p < 0.001; Student’s t test). To demonstrate
that this effect was N1ICD/RBPJK dependent, we used
a dominant-negative RBPJK (Su(H)DBM) that binds to
NICD but is unable to bind to DNA, blocking NICD/
RBPJK-mediated gene activation (Wettstein et al., 1997).
Cotransfection of N1ICD and Su(H)DBM caused a 75%–
80%reduction in luciferaseactivity inbothsites (Figure6F).
To confirm that transcriptional activation occurred specif-
ically via sites A and B, we introduced a single nucleotide
mutation (indicated by the underlined base; 50-GTG
GCAA-30) in both sites (A* or B*). This has been shown to
drastically reduce RBPJK binding to DNA (Tun et al.,
1994). Cotransfection of N1ICD and site A* or site B*
caused an almost complete reduction in luciferase activity
(Figure 6F).
As a control of N1ICD activity, HMEC-1 cells were trans-
fected with a RBPJK-Luc reporter construct (McKenzie
et al., 2005), leading to a 4.5-fold increase in luciferase
activity compared to control cells transfected with empty
vector, and to a 65%–70% reduction of activity upon
cotransfection with Su(H)DBM (Figure 6G). The resultsDevelopmshowed that these two RBPJK-binding sites in the Eph-
rinB2 genomic DNA are functional and activate EphrinB2
transcription. Together our data demonstrate that Eph-
rinB2 is a direct N1ICD/RBPJK target.
DISCUSSION
In this study, we show that Notch is crucial for ventricular
trabeculation and chamber development. EphrinB2 is a
direct endocardial Notch target during this process that
also requires the Notch-dependent activity of BMP10
and NRG1, to promote proliferation and differentiation, re-
spectively, of ventricular myocardium.
Preferential Notch signaling in the trabeculae is evi-
denced by restricted Delta1 and Delta4 transcription,
and N1ICD expression, in the endocardium at the base
of the developing trabeculae. Signal is reduced at the dis-
tal end of trabeculae, suggesting that endocardial Delta-
Notch expression is activated by local cues from the un-
derlying myocardium; the reduction of ligand expression
in the endocardium of Notch mutants (data not shown
and Timmerman et al., 2004) suggests that Notch signals
in the ventricles by lateral induction (Lewis, 1998), and that
N1ICD-expressing endocardial cells behave as a develop-
mental field.
The idea that Notch plays a role in ventricular develop-
ment is supported by the trabeculation-defective pheno-
type of standard and endocardial-specific Notch1 and
RBPJkmutants. Molecular analysis indicates that Notch1
signaling is required for ventricular myocardial differentia-
tion. Interestingly, constitutive cardiac Notch1 activation
driven by Mesp1-CRE leads to impaired ventricular myo-
cardiummaturation and inhibition of cardiomyocyte differ-
entiation (Watanabe et al., 2006). This result might be
thought to be in conflict with our data, but, as the authors
argue, it may be a consequence of ectopic N1ICD myo-
cardial expression in these mice, which may generate ad-
ditional secondary signals that would inhibit cardiomyo-
cyte differentiation (Watanabe et al., 2006).
What are the Notch targets in the heart? Ventricular
expression of the HRT1 and HRT2 transcription factors
(Nakagawa et al., 1999) is unaffected in RBPJk and
Notch1 mutants (see Figure S10), suggesting that other
Notch-dependent genes may be responsible for the regu-
lation of ventricular morphogenesis.
Notchmutants display defective expression and activity
of three signaling pathways that are not classic Notch tar-
gets: BMP10, EphrinB2, and NRG1. BMP10 is required
for cardiomyocyte proliferation (Chen et al., 2004). The re-
duced BMP10 expression in both standard and endocar-
dial-specific Notch mutants suggested that Notch and
BMP10 interact during cardiogenesis. Ventricular BMP10
activity measured by Smad1/5/8 phosphorylation was
clearly reduced in RBPJk mutants. Low BMP10 signaling
was accompanied by reduced cardiomyocyte proliferation
and increased myocardial expression of the cell cycle in-
hibitor p57Kip2. Defective cardiac cellular proliferation
was rescued by culturing RBPJk mutants in BMP10-
conditioned media (Figures 5J and 5O), suggesting that inental Cell 12, 415–429, March 2007 ª2007 Elsevier Inc. 425
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(A) E8.5 WT embryo. A myocardial cue (yellow) leads to N1ICD expression (red) in specific endocardial regions. At E9.0, N1ICD/RBPJK activate en-
docardial EphrinB2, leading to NRG1 expression. NRG1 activates the ErbB2/B4 receptors in the myocardium to induce trabecular muscle differen-
tiation. As the trabecular ridge develops, the endocardium separates from themyocardial N1ICD-inducing cue, and N1ICD is downregulated (pink) at
the tip of the trabeculae. At E9.5–E10.5, N1ICD is higher in the endocardium at the base of the trabeculae, and the ventricular myocardium has dif-
ferentiated into compact zone (green) and trabecular myocardium (blue) regions. The different intensity of N1ICD expression (pink or red) represents
the predominant N1ICD activation at the base of trabeculae in response to a spatially restricted myocardial cue.
(B) Molecular pathways downstream of Notch during trabeculation.
(C) In Notch mutants, proliferation and differentiation signals are disrupted, and trabeculation is impaired.trabecular myocardium Notch modulates proliferation via
BMP10. Proliferation and differentiation, mutually exclu-
sive in skeletal muscle cells (Parker et al., 1995), are inti-
mately linked in cardiomyocytes. Our data indicate that
Notch mutant cardiomyocytes exit the cell cycle prema-
turelyanddonotprogress in theirdifferentiation toward tra-
becular muscle.
NRG1 expression and activity were markedly reduced
in Notch1 and RBPJk embryos, indicating that Notch
and NRG1/ErbB signaling interact during trabecular de-
velopment. NRG1 promotes in vitro proliferation of neona-
tal cardiomyocytes (Zhao et al., 1998); however, in
a whole-mouse embryo culture system, NRG1 induces
trabeculation (Hertig et al., 1999), or cardiac conduction
system development (Rentschler et al., 2002), without
increasing proliferation. Concurring with these results,
we rescued themyocardial differentiation defect ofRBPJk426 Developmental Cell 12, 415–429, March 2007 ª2007 Elsevmutants by culturing them in NRG1-containingmedia (Fig-
ures 5M and 5N).
Cardiac EphrinB2/EphB4 expression and activity were
impaired in Notch mutants, and culture of WT embryos
with DAPT specifically reduced EphrinB2 transcription.
Our ChIP assays demonstrated that N1ICD/RBPJK binds
to two conserved RBPJK-responsive elements within the
EphrinB2 genomic DNA, an association that is lost in vivo
in RBPJk mutants. Reporter assays with endothelial cells
showed that N1ICD specifically activated luciferase ex-
pression downstream of these two sites, demonstrating
that EphrinB2 is a direct transcriptional target of N1ICD/
RBPJK.
How are these signaling mechanisms related? Analysis
of EphrinB2, NRG1, and BMP10 mutants revealed that
cardiac NRG1 transcription was reduced in EphrinB2mu-
tants, whileBMP10mutants showed normal EphrinB2 andier Inc.
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trabeculation endocardial EphrinB2 acts upstream of
NRG1, and that both molecules act independently of
BMP10. Thus, NRG1 could be the secreted ‘‘missing
molecule’’ linking EphrinB2/EphB4 endocardial signaling
to the specific changes described in trabeculating
myocardial cells (Hertig et al., 1999; Rentschler et al.,
2002).
We suggest that during trabeculation Notch links endo-
cardial with myocardial signaling via its direct effect on the
EphrinB2/EphB4 pathway, which is required for endocar-
dial NRG1 production and subsequent ErbB2/B4 activa-
tion in myocardial cells. Notch1 is active in endocardium,
and BMP10 is expressed in myocardium, suggesting that
Notch1 is required for production of a soluble endocardial
signal, which induces myocardial BMP10 expression.
NRG1 was a candidate, but BMP10 expression is normal
in NRG1mutants (Figures 4N and 4N0), indicating that the
NRG1/ErbB pathway does not connect Notch and BMP10
during trabeculation.
Our data show that Notch mediates an endocardium-
myocardium interaction critical for trabeculation and ven-
tricular chamber morphogenesis, identifying two distinct
Notch-dependent processes (summarized in Figure 7):
(1) the transition of primitive myocardial epithelium to
trabecular and compact myocardium (EphrinB2 and
NRG1 dependent), (2) the maintenance of a proliferating
trabecular cardiomyocyte population (BMP10 dependent)
during this transition. In agreement with the proposed cru-
cial role for Notch in trabeculation, constitutive cardiac
Notch1 activation leads to a complex phenotype, includ-
ing ectopic trabeculation in AV myocardium (Watanabe
et al., 2006).
The less dense ventricular compact zone myocardium
in Notch mutants is reminiscent of a CHD termed isolated
ventricular noncompaction (IVNC) (Jenni et al., 2001), a ge-
netically heterogeneous, congenital disorder character-
ized by altered myocardial structure. It is tempting to
speculate that Notch signaling may be altered in infants
with conditions including malseptation, abnormal valve
development (defective papillary muscle formation), or
conduction system defects—all of which are related to
abnormal trabeculation—or in adults as a response to
pathological hypertrophic signals.
EXPERIMENTAL PROCEDURES
Mouse Genotyping
For details, see Supplemental Data.
Histology, In Situ Hybridization, and Immunohistochemistry
Hematoxylin and eosin (H&E) staining was performed by standard
methods. Whole-mount in situ hybridization (WISH) and sectioning
were as described (de la Pompa et al., 1997). Details for probes will
be provided upon request.
For details on immunohistochemistry, see Supplemental Data.
Scanning Electron Microscopy
Mouse embryos were fixed and processed according to standard pro-
tocols.DeveloShort-TermWhole-Mouse Embryo Culture and DAPT Treatment
E8.5 WT mouse embryos were dissected at room temperature in
DMEM/FBS (1:1), leaving all membranes intact. Embryos were cul-
tured in 3 cm tissue culture dishes containing 1ml 1%agarose to avoid
embryo attachment; 2 ml medium (DMEM/FBS [1:1] plus antibiotics
and 50 mM DAPT [g-secretase inhibitor IX; 565770, Calbiochem]) or
DMSO was added to the hardened agarose. Embryos were cultured
(37C, 5% CO2) for 16 hr, then dissected in PBS, fixed in 4% PFA,
and analyzed by WISH.
Short-Term Whole-Mouse Embryo Culture in
Cytokine-Containing Media, Proliferation,
and Marker Analysis of RBPJk Mutants
E8.5 WT and RBPJk mutant embryos were cultured overnight as de-
scribed above in 2 ml BMP10-conditioned media plus 2.5 3 108 M
NRG1 (396-HB/CF; R&D Systems). After overnight culture (16 hr),
BrdU was added to the media at a final concentration of 30 mg/ml,
and the embryos were incubated for an additional 3 hr, followed by fix-
ation and processing for immunostaining or WISH. BMP10-condi-
tioned media were prepared according to Chen et al. (2004).
Analysis of P-Smad1/5/8, ErbB2, and EphrinB2 Phosphorylation
Two independent protein extracts, from 25 E9.5 WT or RBPJk mutant
ventricles each, were prepared. Ventricles were sonicated in RIPA lysis
buffer (50mMTris-HCl [pH 7.5], 0.5%deoxycholate, 150mMNaCl, 1%
NP40, 0.1% SDS, protease, and phosphatase inhibitors). Protein con-
centration was determined by BCA assays (Pierce), and samples were
stored at 80C. Extracts were immunoprecipitated with an antibody
against phosphorylated tyrosine residues (V2171, Promega) (16 hr,
4C). Precipitates or whole extracts were separated by 8%–10%
SDS-PAGE and transferred to Immobilon-P membranes (Millipore).
Western blot was performed with antibodies to the ErbB2 receptor
(SC-284, Santa Cruz Biotechnology), phosphorylated ErbB2 (06-229;
Upstate Biotechnology), phosphorylated EphrinB2 (3481; Cell Signal-
ing), and phospho-Smad1/5/8 (9511; Cell Signaling); for RBPJK, we
used the T6719 rat monoclonal antibody (Hamaguchi et al., 1992).
ECL (Amersham) was used to visualize immunoreactive bands whose
intensity was quantified from digital photoimages with Photoshop.
ChIP Assays
Before crosslinking, embryos were pipetted gently to disaggregate
and homogenize tissue. Chromatin was sheared to an average length
of 0.4–0.8 kb.We used polyclonal (de la Pompa et al., 1997) andmono-
clonal (K0043) (Sakai et al., 1995) antibodies to RBPJK and Notch (Cell
Signaling). PCR amplifications were performed in 25 ml with primers
specific for the promoter analyzed. PCR amplification sensitivity was
evaluated on serial dilutions of total DNA collected after sonication (in-
put fraction). Amplified DNA was separated on 2% agarose gels and
visualized with ethidium bromide. Two sets of primers were used to
amplify 200 bp of DNA sequences containing the two conserved
RBPJK-binding sites of the mouse EphrinB2 gene: forward EphrinB2_
bsA, 50-AACAGCGCATGGAAACTACC-30, and reverse EphrinB2_bsA,
50-CCTTCCTGGGTCTCTTAGGC-30; forward EphrinB2_bsB, 50-ACC
TAGGGCAAGTGGGAACT-30, and reverse EphrinB2_bsB, 50-CAGTG
TTGGGCAGACTGCTA-30. PCR amplification was carried out with
a variable number of cycles (94C for 30 s, 60C for 30 s, 72C for
30 s). For HMEC-1 cells, primers were designed against the highly con-
served binding site 1 of the human EphrinB2 promoter: forward human
EphrinB2_bsA, 50-CATCAACAGCACAGGGAAAC-30, and reverse
human EphrinB2_bsA, 50-CTCTTCCTCCGTGGTGAGTC-30. PCR am-
plification was carried out with a variable number of cycles (94C for
30 s, 59C for 30 s, 72C for 30 s).
Cell Culture, Transfections, Site-Directed Mutagenesis,
and Luciferase Assays
For luciferase assays, we generated a reporter construct by cloning
600 bp and 800 bp DNA fragments containing RBPJK-binding sitespmental Cell 12, 415–429, March 2007 ª2007 Elsevier Inc. 427
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pGL3 promoter luciferase plasmid (Promega).
The sequences of the primers used for site A were 50-ATGGTACCA
GGAGAGGGCTCTTCATCTTGCAG-30 (forward, KpnI site underlined)
and 50-ATCTCGAGGCCTTGTCCGGGTAGAAATCTAAA-30 (reverse,
XhoI site underlined). For site B, the primer sequences used were
(50-30): ATGGTACCCAAATGCCACATAGACTAAGAAAC (forward) and
ATCTCGAGGGCCACTGTAGTGAGAAGCATA (reverse). Mutations
were introduced into these two sites by using the QuikChange Site-
Directed Mutagenesis Kit from Stratagene (La Jolla, CA) according
to the manufacturer’s instructions. We introduced a single nucleotide
mutation (G to C, underlined) in the two RBPJK-binding sites that
has been shown to drastically reduce binding activity (Hamaguchi
et al., 1992). The primers (50 to 30) used to mutate site A were
GGTTAAAAAATAACAAACAGGTGGCAAGGTCTGACTCCCCACCAG
GGG (forward) and CCCCTGGTGGGGAGTCAGACCTTGCCACCTG
TTTGTTATTTTTTAACC (reverse). For site B, the primers (50 to 30)
used were CCTAGCTTCCTACCTAGGGCAAGTGGCAACTTGGTAAA
CATTCAAGGTTTAACC (forward) and GGTTAAACCTTGAATGTTTA
CCAAGTTGCCACTTGCCCTAGGTAGGAAGCTAGG (reverse). The
mutated fragments were recloned into the pGL3 vector, and the intro-
duction of mutations was verified by DNA sequencing. Luciferase re-
porter assays were performed with HMEC-1 cells. HMEC-1 cells were
grown in endothelial cell basal medium-2 (EBM-2 Cambrex, CC-3156)
supplemented with EGM 2 (Cambrex, CC-4176) and 8% FBS. The
cells were seeded in 24-well plates at a density of 5 3 104 cells/
well. Equal amounts (150 ng) of the different EphrinB2 luciferase con-
structs (WT site A, WT site B, mutant site A [*], or mutant site B [*]) or
RBPJk luciferase plasmids; 150 ng pCS2 empty vector, vector encod-
ing N1ICD, or Su(H)DBM; and 10 ng Renilla luciferase were transfected
in triplicate (Fugene6, Roche Diagnostics). pGL3 promoter vector was
added when necessary to keep the DNA amount constant. After 24 hr,
lysates were made and luciferase activity was measured by using the
Dual Luciferase Assay kit (Promega) in a FB15 luminometer (Zylux,
Oak Ridge, TN).
RNA Isolation and Semiquantitative RT-PCR
E8.5–E9.5 WT and RBPJkmutant embryos were dissected in ice-cold
PBS; the heart was separated from the rest of the body and purified
with Trizol (Invitrogen). First-strand cDNA synthesis was performed
by using a First Strand cDNA synthesis kit (Amersham) with 1 mg total
RNA per reaction (for primers and conditions, see Table S1). Amplified
PCR products were cloned in the PCRII-TOPO vector (Invitrogen) and
sequenced. PCR products were quantitated by phosphorimager anal-
ysis (Bio-Rad). For primers details, see Table S1.
Statistics
All results are expressed as means ± SD. An unpaired two-tailed t test
was performed to assess differences between two groups. A p value
of <0.05 was considered significant.
Supplemental Data
Supplemental Data include images from z-stacks of trabecular N1ICD
staining and a corresponding movie; early myocardial and trabecular
marker expression in RBPJk mutants; P-Smad, BrdU, PHH3, and
p57 stainings inRBPJkmutants; comparison of BrdU andN1ICD stain-
ing in WT ventricles; ErbB3 expression in RBPJk mutants; a time
course of EphrinB2, NRG1, and BMP10 transcription; the effect of
DAPT onNRG1 and BMP10 expression; the EphrinB2 sequence align-
ment; and HRT1 and HRT2 expression in Notch pathway mutants and
are available at http://www.developmentalcell.com/cgi/content/full/
12/3/415/DC1/.
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